Litcius/Paper detail

Comparison of renal outcomes between sodium glucose co-transporter 2 inhibitors and glucagon-like peptide 1 receptor agonists

Kazuo Kobayashi, Masao Toyoda, Nobuo Hatori, Hiroyuki Sakai, Takayuki Furuki, Keiichi Chin, Moritsugu Kimura, Nobumichi Saito, Tomohiko Kanaoka, Togo Aoyama, Tomoya Umezono, Shun Ito, Daisuke Suzuki, Hiroshi Takeda, Fuyuki Minagawa, Hisakazu Degawa, Hideo Machimura, Toshimasa Hishiki, Shinichi Umezawa, Hidetoshi Shimura, Shinichi Nakajima, Hareaki Yamamoto, Kazuyoshi Sato, Masaaki Miyakawa, Yasuo Terauchi, Kouichi Tamura, Akira Kanamori

2022Diabetes Research and Clinical Practice15 citationsDOI

Topics & Concepts

MedicineRenal functionAlbuminuriaInternal medicineCreatinineDiabetes mellitusPropensity score matchingIncidence (geometry)EndocrinologyHazard ratioUrologyGastroenterologyConfidence intervalOpticsPhysicsDiabetes Treatment and ManagementChronic Kidney Disease and DiabetesBlood Pressure and Hypertension Studies
Comparison of renal outcomes between sodium glucose co-transporter 2 inhibitors and glucagon-like peptide 1 receptor agonists | Litcius